Key result
Endovascular thrombectomy is established as standard of care for acute ischemic stroke with LVO.
In the past 5 years, the success of multiple randomized controlled trials of recanalization therapy with endovascular thrombectomy has transformed the treatment of acute ischemic stroke with large vessel occlusion. The evidence from these trials has now established endovascular thrombectomy as standard of care. This review will discuss the chronological evolution of large vessel occlusion treatment from early medical therapy with tissue plasminogen activator to the latest mechanical thrombectomy. Additionally, it will highlight the potential areas in endovascular thrombectomy for acute ischemic stroke open to exploration and further progress in the next decade.
No takes yet. Share an insight, caveat, or question.
Shafie et al. (2021) conducted a review in Acute ischemic stroke with large vessel occlusion. Endovascular thrombectomy vs. Medical therapy with tissue plasminogen activator was evaluated. Endovascular thrombectomy has been established as the standard of care for acute ischemic stroke with large vessel occlusion following multiple successful randomized controlled trials.
Synapse has enriched 5 related papers. Consider them for comparative context: